Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma colloid osmotic pressure, also known as oncotic pressure, refers to the component of total blood plasma osmotic pressure that is generated by large plasma proteins—primarily albumin—which are unable to cross capillary walls. This force acts to pull water into the circulatory system and opposes hydrostatic forces that push water out into surrounding tissues. The normal range for plasma colloid osmotic pressure in humans is approximately 25–30 mmHg, with albumin accounting for about 80% of this effect despite being only about half the total protein content in plasma. The balance between hydrostatic and oncotic pressures across capillaries determines net movement of fluid according to Starling’s law; disruption can result in pathological states such as edema when oncotic pressure falls due to loss or decreased synthesis of plasma proteins. Plasma colloid osmotic pressure itself is not a molecular target like an enzyme or receptor but rather a physical property arising from collective action of circulating macromolecules—mainly albumin—and thus should not be considered a therapeutic target per se.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma colloid osmotic pressure.